eNewsroom for: Rosa and Co.

Rosa helps clients with their critical decisions – from preclinical through clinical development – with the creation and use of mathematical models that simulate normal and disease physiology, drug action, patient variability, and trial outcomes. To address the full spectrum of R&D related challenges, Rosa offers customized approaches: classic pharmacokinetic/pharmacodynamic (PK/PD) models and Rosa’s innovative PhysioPD™ models. With these capabilities, Rosa’s clients participate in customized model creation, testing, and research simulations, retain the models, and acquire the ability to perform model research to inform decisions and better understand implications for their drug development programs. Rosa’s staff has unparalleled professional experience in applying modeling and simulation to accelerate drug development and have completed hundreds of engagements with clients in virtually all therapeutic areas, including metabolic diseases, oncology, inflammation, immune dysfunction, CNS, dermatology, and antibacterial/antiviral biology. For more information, visit www.rosaandco.com.

News from Rosa and Co.:

Rosa & Co. to Present Research Results at the 2016 American Conference on Pharmacometrics (ACoP)

SAN CARLOS, Calif., Oct. 11, 2016 /PRNewswire/ — Rosa & Co. LLC, the worldwide commercial leader in PhysioPD™ Research, today announced their participation and poster presentation at ACoP7 to be held in Bellevue, WA on October 23-26, 2016.  The conference will bring together leadi…

Rosa & Co. to Present Research Results With a Poster at the 4th World Parkinson Congress (WPC)

SAN CARLOS, Calif., Sept. 13, 2016 /PRNewswire/ — Rosa & Co. LLC, the leading commercial drug development advisory firm with expertise in quantitative biological PhysioPD™ modeling, today announced their participation and poster presentation at the 4th World Parkinson Congress…

Rosa & Co. to Present Research Results With a Poster at the 2016 World Conference on Pharmacometrics

SAN CARLOS, Calif., Aug. 10, 2016 /PRNewswire/ — Rosa & Co. LLC, the leading commercial drug development advisory firm with expertise in Quantitative Systems Pharmacology (QSP)/PhysioPD™, today announced their participation and presentation of a poster at the 2016 World Conferenc…

Rosa & Co. and MathWorks Host Joint Webinar Discussion on How MATLAB and SimBiology Facilitate Quantitative Systems Pharmacology (QSP) Modeling and Analysis to Support Drug Development

SAN CARLOS, Calif., June 22, 2016 /PRNewswire/ — Rosa & Co. LLC, the leading commercial drug development advisory firm with expertise in QSP/PhysioPD™, today announced their participation in a joint webinar on July 13th, 2016 at 10:00 am and 2:00pm EDT with MathWorks, a developer of mat…

Rosa & Co. to Present at the 7th Annual Shanghai Symposium on Clinical and Pharmaceutical Solutions Through Analysis (CPSA Shanghai 2016): Innovative Approaches to Reduce Attrition and Predict Clinical Outcomes

SAN CARLOS, Calif., April 14, 2016 /PRNewswire/ — Rosa & Co. LLC, the leading commercial drug development advisory firm in Quantitative Systems Pharmacology (QSP)/PhysioPD™, today announced that Ms. Sharan A. Pagano, Senior Vice President of Scientific Alliances will present at th…

Rosa & Co. Participated in the 2016 Roche Quantitative Systems Pharmacology (QSP) Methodology Workshop

SAN CARLOS, Calif., Feb. 9, 2016 /PRNewswire/ — Rosa & Co. LLC, the leading commercial drug development advisory firm with expertise in PhysioPD™/QSP, today announced their participation at the 2016 Roche QSP Methodology Workshop held on February 4 & 5th, 2016 in Basel, Switzerla…

Rosa & Co.'s Dr. Christina Friedrich Publishes "Model Qualification Method for Mechanistic Physiological QSP Models to Support Model-Informed Drug Development" Article in the CPT: Pharmacometrics & Systems Pharmacology Journal

SAN CARLOS, Calif., Feb. 2, 2016 /PRNewswire/ — Rosa & Co. LLC, the leading commercial drug development advisory firm with expertise in Quantitative Systems Pharmacology (QSP)/PhysioPD™, today announced the publication by Dr. Christina Friedrich, "Model Qualification Meth…

Rosa & Co. Presented a Poster at the 2015 Roche Pharma Research and Early Development (pRED) Symposium

SAN CARLOS, Calif., Nov. 6, 2015 /PRNewswire/ — Rosa & Co. LLC, the leading commercial drug development advisory firm with expertise in Quantitative Systems Pharmacology (QSP)/PhysioPD™, today announced their participation and presentation of a poster at the 2015 Roche Pharma Rese…

Rosa & Co. to Present at the 4th Quantitative Systems Pharmacology(QSP) Conference in 2015

Dr. Christina Friedrich to Lead a Workshop at the QSP Congress Meeting in Boston SAN CARLOS, Calif., Oct. 13, 2015 /PRNewswire/ — Rosa & Co. LLC, the leading commercial drug development advisory firm in Quantitative Systems Pharmacology (QSP)/PhysioPD™, today announced that Dr. Chri…

Rosa & Co. to Present Research Results with 5 Posters and a Tutorial at the 2015 American Conference on Pharmacometrics

SAN CARLOS, Calif., Sept. 23, 2015 /PRNewswire/– Rosa & Co. LLC, the leading commercial drug development advisory firm with expertise in Quantitative Systems Pharmacology (QSP)/PhysioPD™, today announced five posters and a tutorial that will be presented during the sixth American…

Rosa & Co. Partners with MathWorks to Advance Quantitative Systems Pharmacology

Leading biological modeling company teams up with leading mathematical software provider to facilitate model-informed drug development. SAN CARLOS, Calif., Sept. ­18, 2015 /PRNewswire/ — Rosa & Co. LLC, the leading commercial drug development advisory firm with expertise in Quant…

Rosa & Co. Sponsors the Inaugural Quantitative Systems Pharmacology (QSP) Tract at the 13th Annual Discovery on Target Conference in Boston

SAN CARLOS, Calif., Aug. 19, 2015 /PRNewswire/ — Rosa & Co. LLC, a drug development advisory firm with expertise in drug-disease modeling and simulation, today announced its pleasure to be a premier sponsor for the Discovery on Target Conference in Boston, MA on September 21-24th, 2015.…

Rosa & Co. Announces Multi-Year, World-Wide PhysioPD™ Research Agreement with Sanofi

SAN CARLOS, Calif., May 28, 2015 /PRNewswire/ — Rosa & Co. LLC, a drug development advisory firm with expertise in drug-disease modeling and simulation, today announced the initiation of a multi-year Research Agreement with Sanofi Global R&D to provide Rosa's market-leading…

Rosa & Co. is the Lead Partner for the Quantitative Systems Pharmacology (QSP) Congress in Basel, Switzerland and Will Present the Keynote Address

SAN CARLOS, Calif., April 28, 2015 /PRNewswire/ — Rosa & Co. LLC, a drug development advisory firm with expertise in drug-disease modeling and simulation, today announced its pleasure to be lead partner for the European conference in the exciting field of Quantitative Systems Pharmacol…

Rosa & Co. Announces Two Poster Presentations at the American Society for Clinical Pharmacology and Therapeutics 2015 Annual Meeting

SAN CARLOS, Calif., March 3, 2015 /PRNewswire/ — Rosa & Co. LLC, a drug development advisory firm with expertise in drug-disease modeling and simulation research, today announced it has two posters scheduled to be presented during the 2015 American Society for Clinical Pharmacology and…

The KressWorks Foundation and Rosa Complete Phase 1 of Ewing's Sarcoma PhysioPD™ Research Platform

SAN CARLOS, Calif., March 28, 2014 /PRNewswire/ — Rosa & Co. LLC and the KressWorks Foundation are pleased to announce the completion of the Ewing's sarcoma PhysioMap®. Completion of the PhysioMap is the first milestone in the development of the Ewing's sarcoma PhysioPD Plat…